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immunological tests. Complex of immuno-
logical investigations comprised determina-
tion in dynamics of the level of antibodies
IgD, IgM to Chlamydia pneumoniae and
Mycoplasma pneumoniae.
Results: Obtained data have shown much
higher incidence of increased antibodies of
IgD and IgM classes in patients with
uncontrollable BA course (47.5% and
37.5% versus 30.0% and 22.5%, respec-
tively). On the basis of obtained results,
correction of therapeutic complex has been
conducted. In positive acute tests
(increased IgM to Chlamydia pneumoniae),
a 14-day course of treatment with antibiot-
ics of the macrolide group (Clarithromycin,
Spiramycin) was included into the basic
therapy. Antibacterial 7-day treatment with
a preparation of the same group was
repeated in 3–4 weeks after the course of
treatment. Therapeutic benefits were esti-
mated by the degree of achieved controlla-
bility of the disease with the use of
classical 5-score scale of the asthma-control
test. Positive dynamics of the indeces of
disease controllability was achieved within
the 1st month of treatment. It has become
more considerable by the end of I.5 month,
remained unaltered and improved during
the entire period of surveillance
(3 months). Terms of response to the ther-
apy were different for each of the indeces,
at that night time symptoms of bronchial
asthma regressed most readily.
Conclusions: Obtained results allowed
determine interrelations between the Chla-
mydia pneumoniae infection and BA con-
trollability. Treatment of a concomitant
infection made it possible in as short as
6 weeks to achieve controllability of the
disease in the majority of patients with the
infection under study.
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Objective: To evaluate the importance of
educational interventions on adherence to
asthma self-management in children.
Methods: Randomised, controlled clinical
study performed in a Regional Centre for
children with asthma. Forty-two children
with persistent asthma (age
9.2 ± 3.1 years; 28 boys) received a writ-
ten asthma plan and instruction on elec-
tronic PEF home-monitoring. The study
group received one-to-one educational
intervention on asthma self-management
delivered by Centre personnel. Adherence
to PEF home-monitoring was assessed
using Piko-1 devices and data were down-
loaded at each of the three monthly visits.
Results: There were no significant differ-
ences on the use of PEF-meters at home
during the first month between the inter-
vention group and the control group. Nev-
ertheless, at 3 months, the intervention
group presented a two-fold better adher-
ence than the controls. Overall, adherence
to home PEF monitoring in intervention
group was below the targeted adherence
(i.e. 61% versus 80%). Children in either
group who were less than 33% adherent to
PEF-monitoring were significantly prone to
asthma symptoms. Asthma exacerbations
were less likely in the intervention group
(0.92 versus 1.3, P = 0.0014).
Conclusion: Our data support the positive
impact of educational interventions on
adherence to asthma self-monitoring in
children.
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Background: Allergy is one of the most
common causes of respiratory symptoms in
children and youth. Asthma is a common
problem in children and the causative pol-
len allergens vary according to the geo-
graphical area.
Objectives: The purpose of this study was
to evaluate the prevalence of atopy, and to
identify the frequency of allergic sensitiza-
tion to pollen allergens, among children
who have asthma, from Jaén (Spain).
Methods: A total of 407 consecutive chil-
dren, younger than 14 year old, 261 male
and 146 female, were recruited from our
outpatient allergy clinic of a general hospi-
tal from Jaén, Patients were arbitrarily
divided into three groups (grs) according
to their age: group 1 = younger than
3 year old (63 patients), group 2 = 4–
6 years (148 patients), and group 3 = 7–
14 years (196 patients). Skin prick testing
was performed to relevant individual aero-
allergens (Lolium perenne, Cynodon dacty-
lom, Cupressus arizonica, Platanus
acerifolia, Olea europaea, Chenopodium
album, Salsola kali, Plantago lanceolata,
Artemisia vulgaris and Parietaria judaica).
Testing for dust mites, cats, dogs, cock-
roach and molds were performed also.
Results: The prevalence of atopy at the
whole sample was of 94.58% (385
patients). 167 of atopic children (43.37%)
showed a positive skin test, only to at least
one of tested pollens. The most common
allergens were Olea europaea (93.5%), fo-
lowed by: Lolium perenne (60.5%) Che-
nopodium (52.2%) and Plantago (43.6%).
The percentage of allergic patients to pol-
lens increased with age for all tested aller-
gens, but the differences were not
significative, except for sensitized to Loli-
um perenne (P = 0.03). Only 30 children
were monosensitized to Olea europaea.
Conclusions: In children with bronchial
asthma from Jaén (Spain), the pollens are
the most frequent cause of respiratory
allergy. Olea europaea is the pollen which
sensitizes more children in our geograhical
area.
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Background: There is a need for simple
reliable tools to assess allergic asthma in
children. In this work, we compare the
parents responses of the upKids-asthma
questionnaire with objective measures used
in daily practice.
Participants and methods: The study sam-
ple was formed by 173 Portuguese school-
children aged 8 to 12 from the urban area
of Porto (51.4% girls). Children’s parents
completed a self-administered question-
naire reporting asthma, physician diagnosis
of asthma and asthma medication. The
questionnaire was based on ISAAC ques-
tionnaire and was developed for assessing
allergic asthma in schoolchildren. Skin
prick tests (SPT) to common aeroallergens
and measurement of exhaled nitric oxide
(FeNO) using NIOX MINO (Aerocrine,
Sweden) were performed. We defined two
groups in the validation analysis: 1) atopics
(positive SPT) with FeNO ‡ 25 ppb and 2)
all the others.
Results: Twelve percent and 15% of the
parents reported physician diagnosis of
asthma and asthma medication use in the
previous year, respectively, however no dif-
ferences in FeNO were observed between
subjects reporting doctor diagnosis or ever
having had asthma. FeNO was signifi-
cantly increased in atopics (mean ± SD
ppb) (34 ± 27 versus 13 ± 8; P < 0.001),
children ever had wheezing (27 ± 25
versus 17 ± 15; P = 0.002), wheezing
with exercise in the last 12 months
(34 ± 28 versus 19 ± 19; P = 0.005), and
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in children using asthma medication in the
last 12 months (31 ± 24 versus 19 ± 15;
P = 0.01). All the questions had low sensi-
tivity, from 16% (ever had asthma) to
73% (ever had wheezing). The questions
specificity ranged between 60% (ever had
wheezing) and 88% (physician diagnosis of
asthma and wheezing with exercise in the
last 12 months). Computing a score with
three questions (ever had asthma, ever had
wheezing and wheezing with exercise in the
last 12 months) no differences were
observed.
Conclusions: FeNO values were signifi-
cantly increased in atopics, children ever
had wheezing or wheezing with exercise
and who did asthma medication in the pre-
vious year. Parents’ individual answers had
poor ability to identify atopic children with
high FeNO values. Questionnaires and
objective measures may complement each
other in this assessment.
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Background: This open-label study ana-
lyzed the first 1-year experience of anti-
IgE-treatment in childhood asthma in
Russia.
Methods: Efficacy and tolerability of oma-
lizumab in 15 adolescents (12–17 years; 8
males) with severe persistent alllergic
asthma inadequately controlled on high-
dose inhalled corticosteroides has been
established. Omalizumab (225–375 mg) was
administred subcutaneously once every 2
or 4 weeks. Dose was individualized for
each patient based on the body weight and
total serum IgE level at the first visit.
Results: Omalizumab significantly reduced
the rate of severe asthma exacerbation by
65% and the rate of hospitalisation by
78% after 6 month of treatment. Oma-
lizumab significantly improved asthma-
related quality of life and asthma symptom
scores. In two of 3 of patients achieved a
‡50% reduction in inhaled corticosteroides
dose. Fluticasone dose reduction to
£500 lg/day occurred in ½ patients. No
serious adverse events on omalizumab was
shown. The tolerability of anti-IgE-treat-
ment was good in all adolescents.
Conclusions: Omalizumab treatment
improves asthma control in severely young
allergic asthmatics, reduces the rate of clin-
ically significant exacerbations and asthma-
related hospitalisations, and reduces
inhaled corticosteroides and rescue medica-
tion requirements. Omalizumab is effective
and should be considered as add-on ther-
apy for adolescents with inadequatelly con-
trolled severe persistent asthma despite
therapy with high-dose inhaled corticoste-
roides.
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Aim: We intend to evaluate relationship
between body mass index (BMI) and bron-
chial hyper responsiveness (BHR) degree in
children with bronchial asthma.
Material and methods: Retrospective study
performed at the Department for asthma
and allergic diseases at the Institute. This
study involved 220 children with asthmatic
diseases, at the age of 7 to 15 years
(approximately 9.8 years.); 149 male and
89 female. BMI was calculated as weight/
height2 (kg/m2). In all children BHR
degree was detected with broncho-provoca-
tion test with PD20 histamine chloride: 1.
children with manifested mild BHR degree
who reacted on PD20–2000 lg histamine
chloride; 2. children with moderate BHR
degree with reaction on PD20–500 lg his-
tamine chloride; 3. children with intensive
BHR degree reaction on PD20–125 lg his-
tamine chloride.
Results: Our patients were divided in three
groups: I. BMI <20 in 93 (40.6%) chil-
dren; II. BMI = 20–24 in 88 (38.4%); III.
BMI "d20 in 48 (20.9%). We had results
as follows: I. group: 6.7% children with
BHR mild degree, 39% with moderate
degree = 39% and with intensive BHR
degree = 49.5%; in second group
P = 13.6% with mild, 36.6% with moder-
ate and 51.1% with intensive BHR degree;
in third grouP = 12.5% children were
with mild, 37.5% with moderate and 50%
with intensive BHR degree.
Conclusion: We had no confirmed differ-
ence in all three groups of our patients,
association between BMI and BHR was
not verified, respectively.
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Background: Quality of life in children
with asthma correlates closely and is a
result of the diseases control. Pediatric
Asthma Quality of Life Questionnaire-
PAQLQ by Juniper has been developed to
measure asthma specific quality of life in
children. The aim of the study was to
translate and adapt the PAQLQ into Mac-
edonian.
Methods: The investigation included 15
asthma children aged between 7–17 years,
with Macedonian as a native language.
PAQLQ self/interviewer-administered
forms were translated into Macedonian by
Mapi research institute, Lion, France. 10
children completed the interviewer-admin-
istered form, 5 of them aged 10 years and
older completed the self-administered form
too, and 5 children only the self-adminis-
tered form.
Results: The younger age group completed
the questionnaire in 15 min, and the older
one in 10 min. Generally, the questionnaire
was clear and easy to understand, and chil-
dren didn’t have difficulties in selecting
answers at the response scale. Three chil-
dren added ‘dancing in folklore group’ into
the offered activities. The word ‘irritated’
most of the children changed into ‘ner-
vous’, and ‘different’ into ‘other’.
Conclusion: The Macedonian version of
the PAQLQ was acceptable with a few
changes which were implemented in the
questionnaire by MAPI. Validation of
PAQLQ in The Republic of Macedonia is
in progress.
Key words: Pediatric asthma, quality of
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Background: Currently available anti-
inflammatory treatment for first line ther-
apy in pre-school asthma includes inhaled
corticosteroids (ICS) and the leukotriene
receptor antagonist (LTRA) montelukast.
Poster Group 3 – Pediatric Asthma II
 2009 The Authors
442 Journal Compilation  2009 Blackwell Publishing Ltd Allergy 64 (Suppl. 90): 179–538
